Date of Realization
Leerink Swann is a niche-oriented, full-service investment bank, focused on the life sciences market, offering institutional sales and trading, equity research, corporate finance, corporate consulting, and private client services to high-net-worth clients. Leerink provides insightful, current, value-added industry intelligence through its unique market perspective coming from both its proprietary network of over 35,000 professionals in the life science market and its exclusive relationship with Humedica, a company founded by Leerink that provides real world insights into clinical outcomes. Leerink’s deep industry expertise, proven product distribution capabilities, and recognized position as a premier source for life science equity research has enabled the Company to capitalize on the rapidly expanding and increasingly segmented life sciences industry.
Founded in 1995, Leerink has over 200 full time employees spread across its offices in Boston, New York, and San Francisco.
In 2007, Lovell Minnick Partners completed a growth capital investment in the Company, and made a follow-on investment in 2011. Leerink reacquired LMP's equity interest in April 2013.www.leerink.com